drugset / Trial / NCT00385086

Lumbar Spinal Fibrosis and TNF Alpha Inhibition

NCT00385086

RandomizedParallel-groupDouble-blindTreatment

Summary

TNF-alpha is the main cytokine implicated in the formation of lumbar spinal fibrosis. Inhibiting TNF-alpha could significantly decrease spinal fibrosis after lumbar discectomy.

Timeline

Start
2007-02
Primary completion
2012-10
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Infliximab Monoclonal antibody 3 mg/kg Intravenous